The structural profiles are close, with Neurocrine Biosciences carrying a narrow edge on valuation. Penumbra still has the edge on profitability, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward Penumbra, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Neurocrine Biosciences, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels.
The lead runs through valuation, while profitability still acts as a real counterweight on the other side.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
The pair sits on a clearly comparable long-term path, though it is not a near-twin match.
The match is driven mainly by investment intensity and recent revenue growth.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Pricing shapes this comparison more than a broad operating gap.
Left means cheaper relative valuation. Higher means stronger structure.
The structural gap is limited here, but current pricing still leans against Penumbra, Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The multiple-based pricing edge comes from a forward P/E that is 38 turns lower.
Profitability still tilts materially toward Penumbra, Inc., which stops the result from looking dominant across the whole profile.
Valuation is the clearest driver of the lead, with profitability adding further support — though profitability still provides a real counterweight.
Break down the NBIX vs PEN comparison across all dimensions with the full interactive tool.
Explore how NBIX and PEN each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.